Uncategorised Archives - Pharma Globenewswire

Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast 2034

DelveInsight’s “Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Knee Osteoarthritis, historical and forecasted epidemiology as well as the Knee Osteoarthritis market trends in the United States, EU4 (Germany, France, Italy, Spain) and the United

17 April 2026

Uncategorised

Sarcopenia Market to Grow from USD 2,276 Million in 2025 to USD 5,626 Million in 2034 | DelveInsight

DelveInsight’s “Sarcopenia Market Insights, Epidemiology, and Market Forecast 2034” report delivers an in-depth understanding of the Sarcopenia, historical and forecasted epidemiology as well as the Sarcopenia market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom,

17 April 2026

Uncategorised

Non-postoperative Acute Pain Market Size Valued at USD 3,600 Million in 2023 | DelveInsight

DelveInsight’s “Non-postoperative Acute Pain Market Insights, Epidemiology, and Market Forecast 2034” report delivers an in-depth understanding of the Non-postoperative Acute Pain, historical and forecasted epidemiology as well as the Non-postoperative Acute Pain market trends in the United States, EU4 (Germany, France, Italy,

17 April 2026

Uncategorised

Traumatic Brain Injury Market Projected to Reach USD 30 Billion in 2024, Growing at 10.9% CAGR Through 2034

DelveInsight’s “Traumatic Brain Injury Market Insights, Epidemiology, and Market Forecast 2034” report delivers an in-depth understanding of the Traumatic Brain Injury, historical and forecasted epidemiology as well as the Traumatic Brain Injury market trends in the United States, EU4 (Germany, France, Italy,

17 April 2026

Uncategorised

Systemic Sclerosis Market Projected to Reach ~USD 2,660 Million by 2034

The Systemic Sclerosis Market Size was valued at approximately USD 1,937 million in 2025 and is anticipated to grow with a significant CAGR of 3.6% to reach around USD 2,660 million by 2034 during the study period (2020-2034), according to DelveInsight’s comprehensive

17 April 2026

Uncategorised

IgG4-Related Disease Market Set to Surge at 34.60% CAGR, Reaching New Heights by 2034 Driven by Emerging Therapies and Rising Disease Awareness Globally

IgG4-Related Disease Market Summary The IgG4-Related Disease market is witnessing a transformative period of growth and clinical advancement. Valued at approximately USD 182 million in 2025 across the 7 Major Markets (7MM), the market is projected to expand at a remarkable CAGR

17 April 2026

Uncategorised

Inflammatory Myositis Market Set for Remarkable Growth: Projected CAGR of 11.7% Through 2034 Driven by Emerging Therapies and Rising Patient Demand Across Seven Major Markets

Inflammatory Myositis Market In 2023, the Inflammatory myositis market in the US stood out prominently among the seven major markets (7MM), reaching an impressive USD 301 million. This significant figure not only underscores the current robust demand but also highlights the substantial

16 April 2026

Uncategorised

Chronic Spontaneous Urticaria Market Set to Surpass USD 2000 Million by 2025, Driven by Emerging Biologics, Rising Disease Awareness, and Expanding Global Treatment Access

Chronic Spontaneous Urticaria Market Summary The Chronic Spontaneous Urticaria market has emerged as one of the most dynamically evolving segments within immunodermatology. The Chronic Spontaneous Urticaria market size in the 7 Major Markets (7MM) – comprising the United States, EU4 countries (Germany,

16 April 2026

Uncategorised

WHIM Syndrome Market: Epidemiology Insights, Emerging Therapies, Pipeline Analysis, and Growth Forecast Across the 7 Major Markets Through 2034

WHIM Syndrome Market The Whim Syndrome market is gaining increased attention from the global healthcare and pharmaceutical community as rare disease awareness expands and novel therapeutic approaches begin to emerge. WHIM syndrome is a rare genetic disorder caused by CXCR4 mutations, leading

14 April 2026

Uncategorised

Allergic Rhinitis Market Set to Surge Beyond USD 3,600 Million as Emerging Therapies and Rising Global Prevalence Drive Substantial Growth Through 2034

Allergic Rhinitis Market The Allergic Rhinitis market is witnessing a period of significant transformation, driven by rising disease prevalence, expanding treatment pipelines, and growing awareness across the seven major markets (7MM) – the United States, Germany, France, Italy, Spain, the United Kingdom,

13 April 2026

Uncategorised

Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market was approximately USD 3 billion in 2024, Estimates DelveInsight

Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast 2034

Sarcopenia Market to Grow from USD 2,276 Million in 2025 to USD 5,626 Million in 2034 | DelveInsight

Non-postoperative Acute Pain Market Size Valued at USD 3,600 Million in 2023 | DelveInsight

Traumatic Brain Injury Market Projected to Reach USD 30 Billion in 2024, Growing at 10.9% CAGR Through 2034

Systemic Sclerosis Market Projected to Reach ~USD 2,660 Million by 2034

Inflammatory Myositis Market Set for Remarkable Growth: Projected CAGR of 11.7% Through 2034 Driven by Emerging Therapies and Rising Patient Demand Across Seven Major Markets

Chronic Spontaneous Urticaria Market Set to Surpass USD 2000 Million by 2025, Driven by Emerging Biologics, Rising Disease Awareness, and Expanding Global Treatment Access

WHIM Syndrome Market: Epidemiology Insights, Emerging Therapies, Pipeline Analysis, and Growth Forecast Across the 7 Major Markets Through 2034

Allergic Rhinitis Market Set to Surge Beyond USD 3,600 Million as Emerging Therapies and Rising Global Prevalence Drive Substantial Growth Through 2034

Recent Posts

Banner

Newsletter

Authors

pharmaglobenews

Michael Ashford

FDA Approves Otsuka’s VOYXACT (Sibeprenlimab-szsi): A Breakthrough in Primary Immunoglobulin A Nephropathy Treatment

Suggestions

Uncategorised

Recent Posts

Banner

Newsletter

Authors